Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines
- PMID: 16869729
- DOI: 10.1359/jbmr.060512
Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines
Abstract
Because DIF-1 has been shown to affect Wnt/beta-catenin signaling pathway, the effects of DIF-1 on osteoblast-like cell lines, SaOS-2 and MC3T3-E1, were examined. We found that DIF-1 inhibited this pathway, resulting in the suppression of ALP promoter activity through the TCF/LEF binding site.
Introduction: Differentiation-inducing factor-1 (DIF-1), a morphogen of Dictyostelium, inhibits cell proliferation and induces cell differentiation in several mammalian cells. Previous studies showed that DIF-1 activated glycogen synthase kinase-3beta, suggesting that this chemical could affect the Wnt/beta-catenin signaling pathway. This pathway has been shown to be involved in bone biology.
Materials and methods: We studied the effects of DIF-1 on SaOS-2 and MC3T3-E1, osteosarcoma cell lines widely used as a model system for ostoblastic cells and murine osteoblast-like cell line, respectively. Reporter gene assays were also carried out to examine the effect of DIF-1 on the Wnt/beta-catenin signaling pathway.
Results: DIF-1 inhibited SaOS-2 proliferation and reduced alkaline phosphatase (ALP) activity in a concentration- and a time-dependent manner. The expression of ALP was markedly suppressed by DIF-1-treatment in protein and mRNA levels. DIF-1 also suppressed the expression of other osteoblast differentiation markers, including core binding factor alpha1, type I collagen, and osteocalcin, in protein and mRNA levels and inhibited osteoblast-mediated mineralization. Subsequently, we examined the effect of DIF-1 on the Wnt/beta-catenin signaling pathway. We found that DIF-1 suppressed the expression of beta-catenin protein and the activity of the reporter gene containing T-cell factor/lymphoid enhancer-binding factor (TCF/LEF) consensus binding sites. We examined the effect of DIF-1 on a reporter gene driven by the human ALP promoter and found that DIF-1 significantly reduced the ALP reporter gene activity through the TCF/LEF binding site (-1023/-1017 bp). Furthermore, the effect of DIF-1 on MC3T3-E1, a murine osteoblast-like cell line, was examined, and it was found that DIF-1 suppressed ALP mRNA expression by the reduction of the ALP reporter gene activity through the TCF/LEF binding site.
Conclusions: Our data suggest that DIF-1 inhibits Wnt/beta-catenin signaling, resulting in the suppression of ALP promoter activity. To our knowledge, this is the first report to analyze the role of the TCF/LEF binding site (-1023/-1017 bp) of the ALP gene promoter in osteoblast-like cell lines.
Similar articles
-
Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.Bone. 2008 Apr;42(4):669-80. doi: 10.1016/j.bone.2007.12.006. Epub 2007 Dec 27. Bone. 2008. PMID: 18294945
-
DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.Biochem Pharmacol. 2012 Jan 1;83(1):47-56. doi: 10.1016/j.bcp.2011.10.001. Epub 2011 Oct 8. Biochem Pharmacol. 2012. PMID: 22005519
-
Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells.Biochem Biophys Res Commun. 2005 Dec 16;338(2):903-9. doi: 10.1016/j.bbrc.2005.10.018. Epub 2005 Oct 14. Biochem Biophys Res Commun. 2005. PMID: 16243295
-
The Wnt/beta-catenin pathway in adrenocortical development and cancer.Mol Cell Endocrinol. 2011 Jan 30;332(1-2):32-7. doi: 10.1016/j.mce.2010.11.014. Epub 2010 Nov 20. Mol Cell Endocrinol. 2011. PMID: 21094679 Review.
-
Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs.J Pharmacol Sci. 2009 Feb;109(2):179-83. doi: 10.1254/jphs.08r28fm. Epub 2009 Jan 29. J Pharmacol Sci. 2009. PMID: 19179804 Review.
Cited by
-
Dental regenerative therapy targeting sphingosine-1-phosphate (S1P) signaling pathway in endodontics.Jpn Dent Sci Rev. 2020 Nov;56(1):127-134. doi: 10.1016/j.jdsr.2020.09.002. Epub 2020 Oct 13. Jpn Dent Sci Rev. 2020. PMID: 33088365 Free PMC article. Review.
-
17β-Estradiol (E2) Activates Matrix Mineralization through Genomic/Nongenomic Pathways in MC3T3-E1 Cells.Int J Mol Sci. 2024 Apr 26;25(9):4727. doi: 10.3390/ijms25094727. Int J Mol Sci. 2024. PMID: 38731947 Free PMC article.
-
SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts.BMC Mol Biol. 2010 Feb 3;11:13. doi: 10.1186/1471-2199-11-13. BMC Mol Biol. 2010. PMID: 20128911 Free PMC article.
-
ER stress regulates alkaline phosphatase gene expression in vascular smooth muscle cells via an ATF4-dependent mechanism.BMC Res Notes. 2018 Jul 16;11(1):483. doi: 10.1186/s13104-018-3582-4. BMC Res Notes. 2018. PMID: 30012221 Free PMC article.
-
Wnt/β-catenin expression does not correlate with serum alkaline phosphatase concentration in canine osteosarcoma patients.PLoS One. 2011;6(10):e26106. doi: 10.1371/journal.pone.0026106. Epub 2011 Oct 11. PLoS One. 2011. PMID: 22022527 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources